SB 328437

CAS No. 247580-43-4

SB 328437( (S)-methyl 2-(1-naphthamido)-3-(4-nitrophenyl)propanoate | ZINC29222893 )

Catalog No. M27704 CAS No. 247580-43-4

SB 328437 is an effective and selective antagonist of CCR3 (IC50 = 4.5 nM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 87 In Stock
10MG 140 In Stock
25MG 282 In Stock
50MG 462 In Stock
100MG 672 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    SB 328437
  • Note
    Research use only, not for human use.
  • Brief Description
    SB 328437 is an effective and selective antagonist of CCR3 (IC50 = 4.5 nM).
  • Description
    SB 328437 is an effective and selective antagonist of CCR3 (IC50 = 4.5 nM).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    (S)-methyl 2-(1-naphthamido)-3-(4-nitrophenyl)propanoate | ZINC29222893
  • Pathway
    Autophagy
  • Target
    CCR
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    247580-43-4
  • Formula Weight
    378.38
  • Molecular Formula
    C21H18N2O5
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 125 mg/mL (330.36 mM)
  • SMILES
    COC(=O)[C@H](Cc1ccc(cc1)[N+]([O-])=O)NC(=O)c1cccc2ccccc12
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Stefanie Flohr, et al. 5-membered heteroarylcarboxamide derivatives as plasma kallikrein inhibitors. WO2013111108A1
molnova catalog
related products
  • Leronlimab

    Leronlimab (PRO 140) is a humanized IgG4 anti-CCR5 monoclonal antibody with both anti-HIV and anti-tumor activity, inhibiting CCR-mediated HIV-1 virus and cancer cell metastasis in mouse tumor models. Leronlimab can be used to study HIV, non-alcoholic steatohepatitis (NASH), and breast cancer.

  • Maraviroc

    Maraviroc is a CCR5 antagonist for MIP-1α, MIP-1β and RANTES with IC50 of 3.3 nM, 7.2 nM and 5.2 nM, respectively.

  • CCR2 antagonist 4

    CCR2 antagonist 4 is a potent and specific antagonist of CCR2(IC50s of 180 nM), and potently inhibits MCP-1-induced chemotaxis(IC50 of 24 nM).